Probing the role of interfacial residues in a dimerization inhibitor of HIV-1 protease

被引：17

作者：

Shultz, MD ^{[1
]}

Chmielewski, J ^{[1
]}

机构：

[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 16期

关键词：

D O I：

10.1016/S0960-894X(99)00400-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The importance of each side chain of a cross-linked interfacial peptide inhibitor of HIV-1 protease was evaluated using an alanine scanning approach. Whereas the parent inhibitor has an IC50 value of 350 nM, values for the mutations reported here range from 280 - 9200 nM. The relative importance or each residue was thus assigned and correlated to the solvent accessible surface area (SASA) exposed upon mutation. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：2431 / 2436

页数：6

共 32 条

[1] SYNTHETIC INTERFACE PEPTIDES ALTER DIMERIC ASSEMBLY OF THE HIV-1 AND HIV-2 PROTEASES
BABE, LM
ROSE, J
CRAIK, CS
[J]. PROTEIN SCIENCE, 1992, 1 (10) : 1244 - 1253
[2] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
Carr, A
Samaras, K
Burton, S
Law, M
Freund, J
Chisholm, DJ
Cooper, DA
[J]. AIDS, 1998, 12 (07) : F51 - F58
[3] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
Carr, A
Samaras, K
Chisholm, DJ
Cooper, DA
[J]. LANCET, 1998, 351 (9119) : 1881 - 1883
[4] Recent developments in HIV protease inhibitor research
Chrusciel, RA
Romines, KR
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (02) : 111 - 121
[5] A HOT-SPOT OF BINDING-ENERGY IN A HORMONE-RECEPTOR INTERFACE
CLACKSON, T
WELLS, JA
[J]. SCIENCE, 1995, 267 (5196) : 383 - 386
[6] COMPARATIVE-ANALYSIS OF THE SEQUENCES AND STRUCTURES OF HIV-1 AND HIV-2 PROTEASES
GUSTCHINA, A
WEBER, IT
[J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1991, 10 (04): : 325 - 339
[7] Hypertrophy of the breasts in a patient treated with indinavir
Herry, I
Bernard, L
deTruchis, P
Perronne, C
[J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (04) : 937 - 938
[8] KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413
[9] EFFECT OF POINT MUTATIONS ON THE KINETICS AND THE INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE - RELATIONSHIP TO DRUG-RESISTANCE
LIN, YZ
LIN, XL
HONG, L
FOUNDLING, S
HEINRIKSON, RL
THAISRIVONGS, S
LEELAMANIT, W
RATERMAN, D
SHAH, M
DUNN, BM
TANG, J
[J]. BIOCHEMISTRY, 1995, 34 (04) : 1143 - 1152
[10] Molecular basis of resistance to HIV-1 protease inhibition:: A plausible hypothesis
Luque, I
Todd, MJ
Gómez, J
Semo, N
Freire, E
[J]. BIOCHEMISTRY, 1998, 37 (17) : 5791 - 5797

← 1 2 3 4 →